Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry

Conclusions: According to our results, it could be concluded that the difference in the rate of MACE between the ZES and EES groups was not statistically significant at 12-month follow up.
Source: Therapeutic Advances in Cardiovascular Disease - Category: Cardiology Authors: Tags: Original Research Source Type: research